Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
4321
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
Published 2025-02-01Get full text
Article -
4322
Erratum to “DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil”
Published 2014-01-01Get full text
Article -
4323
-
4324
Endometrial Carcinoma in a 26-Year-Old Patient with Bardet-Biedl Syndrome
Published 2018-01-01Get full text
Article -
4325
Misdiagnosis of Extensive Maxillofacial Infection and Its Relationship with Periodontal Problems and Hyperglycemia
Published 2016-01-01“…The patient was then referred to oral oncology center by emergency physician with cancer suspicion. …”
Get full text
Article -
4326
Clinical Manifestations of Hemochromatosis in HFE C282Y Homozygotes Identified by Screening
Published 2008-01-01Get full text
Article -
4327
Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
Published 2024-12-01“…Target prediction using SwissTarget and PPB2 identified five carbonic anhydrases, which are also targets of oncology drugs, as common targets for the disaccharides. …”
Get full text
Article -
4328
-
4329
A Case of a Gastrointestinal Stromal Tumor Diagnosed at the Postpartum Period
Published 2016-01-01Get full text
Article -
4330
-
4331
Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome
Published 2015-01-01Get full text
Article -
4332
-
4333
-
4334
Development of a UPLC-MS/MS Method for the Quantification of VS-5584 and Its Application in Pharmacokinetic Studies in Rats
Published 2020-01-01“…VS-5584 is a small-molecular compound that showed equivalent activity against mTOR and all class I PI3K isoforms and demonstrated preclinical activity in diverse cancer cell lines and xenograft tumor model, and rational combination of VS-5584 and other target therapies achieved promising outcomes in oncology. In the present study, we established and validated a simple and sensitive UPLC-MS/MS method for the determination of VS-5584 in plasma samples. …”
Get full text
Article -
4335
-
4336
Secondary Budd–Chiari syndrome caused by renal cell carcinoma with hepatic vein invasion: case report
Published 2025-01-01“…Following an uneventful postoperative period, the patient was discharged in good condition and referred to the oncology department for further management. Conclusions This situation highlights the need to consider the possibility of secondary Budd–Chiari syndrome in patients with large renal cell carcinoma. …”
Get full text
Article -
4337
B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody
Published 2017-01-01Get full text
Article -
4338
Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients
Published 2017-01-01Get full text
Article -
4339
-
4340
Mapping Pituitary Neuroendocrine Tumors: An Annotated MRI Dataset Profiling Tumor and Carotid Characteristics
Published 2025-01-01“…Our initiative addresses the need for standardized data in pituitary oncology, fosters collaboration and innovation, and enables the development and benchmarking of workflows that utilize pituitary radiomics for treatment planning and outcome prediction.…”
Get full text
Article